T38715 |
MSDC-0602K
|
1314533-27-1
|
99.89%
|
|
MSDC-0602K (Azemiglitazone potassium) (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25...
|
T17044 |
Tesaglitazar
|
251565-85-2
|
99.89%
|
|
Tesaglitazar is a potent and selective peroxide PPARα / γ receptor dual agonist with a more potent affinity for PPARγ than PPARα, The EC50 values for rat PPARα a...
|
TN1836 |
Kudinoside D
|
173792-61-5
|
99.88%
|
|
Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
|
T1298 |
Clofibrate
|
637-07-0
|
99.87%
|
|
Clofibrate (Clofibrato) is an aryloxyisobutyric acid derivate with antihyperlipidemic activity.
|
T0334 |
Rosiglitazone
|
122320-73-4
|
99.87%
|
|
Rosiglitazone (BRL49653) is a PPARγ agonist, TRPC5 activator, and TRPM3 inhibitor with oral activity. Rosiglitazone is also a hypoglycemic agent and a thiazolidi...
|
T0509 |
Cloxiquine
|
130-16-5
|
99.84%
|
|
Cloxiquine (Dermofongin) is a monohalogenated 8-hydroxyquinoline with activity against bacteria, fungi, and protozoa.
|
T2269 |
Pirinixic Acid
|
50892-23-4
|
99.83%
|
|
Pirinixic Acid (NSC 310038) is a synthetic thiacetic acid derivative used in biomedical research, carcinogenic Pirinixic acid is a peroxisome proliferator that a...
|
T6524 |
GW0742
|
317318-84-6
|
99.83%
|
|
GW0742 (GW610742) is an effective and specific PPARδ agonist (EC50: 1 nM/1.1 μM/2 μM, for human PPARδ/α/γ).
|
TN3609 |
Catalposide
|
6736-85-2
|
99.82%
|
|
Catalposide is a potent inducer of (HO)-1 isolated from Catalpa ovate G. Don (Bignoniaceae). Catalposide possesses antioxidant, anti-apoptotic, anti-microbial, a...
|
T0841 |
Bezafibrate
|
41859-67-0
|
99.82%
|
|
Bezafibrate (BM15075) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPRO...
|
T6646 |
Rosiglitazone hydrochloride
|
302543-62-0
|
99.79%
|
|
Rosiglitazone hydrochloride (BRL-49653 HCl) is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
|
T12296 |
Oleoylethanolamide
|
111-58-0
|
99.79%
|
|
Oleoylethanolamide (N-Oleoylethanolamide) is a high affinity endogenous agonist of PPAR-α.
|
T3138 |
Astaxanthin
|
472-61-7
|
99.79%
|
|
Astaxanthin (trans-Astaxanthin) is a keto-carotenoid in the terpenes class of chemical compounds. It is classified as a xanthophyll but it is a carotenoid with n...
|
T2985 |
Gypenoside XLIX
|
94987-08-3
|
99.78%
|
|
Extracted from whole herb of Gynostemsma pentaphyllum(Thunb.)Mak.;Store the product in sealed, cool and dry condition
|
T1674 |
Nateglinide
|
105816-04-4
|
99.78%
|
|
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy ...
|
T6893 |
MK-886
|
118414-82-7
|
99.78%
|
|
MK-886 (L 663536) is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagoni...
|
T2932 |
Ginsenoside Rh1
|
63223-86-9
|
99.77%
|
|
Ginsenoside Rh1 (Sanchinoside B2) , one of the main constituents of Panax ginseng, exhibits anti-inflammatory effect.
|
T21598L |
G3335 Acetate
|
T21598L
|
99.75%
|
|
G3335 Acetate was discovered to be a novel PPARgamma antagonist.
|
T15575 |
Indeglitazar
|
835619-41-5
|
99.73%
|
|
Indeglitazar (PPM 204) is orally available pan-agonist of PPAR (PPAR subtypes alpha (α), delta (δ), and gamma (γ)).
|
T4S2128 |
Bilobetin
|
521-32-4
|
99.73%
|
|
Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet.
|